The goal of the MCBDTP is to train PhD and MD/PhD scientists who will advance research in experimental Pathology and the molecular and cellular basis of disease. The MCBDTP provides a PhD training ...

This study investigates the potential clinical synergy between the PARP inhibitor niraparib (Zejula) and concomitant statins, exploring their combined effects on progression-free survival (PFS) in ...

These shifts highlight specific molecular mechanisms, such as immune activation and structural integrity decline, across various cell types. These findings could help reveal brain regions and ...

As he opened his address, the Professor of Integrative Pathology at the Institute of Cancer Research in London (ICR) and Professor of Molecular Pathology at Queen’s University Belfast (QUB) reflected ...

The panel of experts at the ISP felt strongly that localization of pheochromocytoma or paraganglioma should only be initiated if the clinical evidence for the presence of tumor is reasonably ...

Recent research has focused on identifying germline polymorphisms associated with risk of glioma, and using molecular markers to classify glial tumors into more-homogenous groups. Because gene ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...